ERBB3 and ODF2L |
erb-b2 receptor tyrosine kinase 3 |
outer dense fiber of sperm tails 2-like |
|
|
|
|
|
|
ERBB3 and TNS4 |
erb-b2 receptor tyrosine kinase 3 |
tensin 4 |
|
|
|
|
|
|
ERBB3 and SOS1 |
erb-b2 receptor tyrosine kinase 3 |
son of sevenless homolog 1 (Drosophila) |
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Signaling by FGFR in disease
- SHC-mediated cascade
- FCERI mediated MAPK activation
- Platelet Aggregation (Plug Formation)
- Signaling by EGFRvIII in Cancer
- SHC1 events in ERBB2 signaling
- Signaling by SCF-KIT
- DAP12 signaling
- Regulation of KIT signaling
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Interleukin receptor SHC signaling
- Gastrin-CREB signalling pathway via PKC and MAPK
- SOS-mediated signalling
- SHC-mediated signalling
- Signaling by PDGF
- DAP12 interactions
- SHC-related events triggered by IGF1R
- GRB2 events in EGFR signaling
- Signaling by ERBB4
- Role of LAT2/NTAL/LAB on calcium mobilization
- Signaling by ERBB2
- Signaling by EGFR
- GPCR downstream signaling
- Signaling by Interleukins
- SHC1 events in ERBB4 signaling
- Signalling to RAS
- Downstream signal transduction
- Signaling by Rho GTPases
- Signaling by FGFR mutants
- Signaling by EGFR in Cancer
- Fc epsilon receptor (FCERI) signaling
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- Signalling to ERKs
- Axon guidance
- IRS-mediated signalling
- IGF1R signaling cascade
- Rho GTPase cycle
- IRS-related events triggered by IGF1R
- EGFR Transactivation by Gastrin
- GRB2 events in ERBB2 signaling
- Activation of Rac
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- NCAM signaling for neurite out-growth
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Innate Immune System
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- Cell death signalling via NRAGE, NRIF and NADE
- SOS-mediated signalling
- SHC-mediated signalling
- Integrin alphaIIb beta3 signaling
- p75 NTR receptor-mediated signalling
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- NGF signalling via TRKA from the plasma membrane
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- SHC-related events
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- Signaling by FGFR
- SHC1 events in EGFR signaling
- FRS2-mediated cascade
- IRS-mediated signalling
- Signal attenuation
- NRAGE signals death through JNK
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- Interleukin receptor SHC signaling
- FCERI mediated Ca+2 mobilization
- Constitutive Signaling by EGFRvIII
- Signaling by Robo receptor
|
|
|
|
|
ERBB3 and NCK2 |
erb-b2 receptor tyrosine kinase 3 |
NCK adaptor protein 2 |
|
- Signaling by PDGF
- Ephrin signaling
- Axon guidance
- Activation of Rac
- Signaling by VEGF
- Downstream signal transduction
- EPH-Ephrin signaling
- Nephrin interactions
- Signaling by Robo receptor
- VEGFA-VEGFR2 Pathway
|
|
|
|
|
ERBB3 and HCK |
erb-b2 receptor tyrosine kinase 3 |
HCK proto-oncogene, Src family tyrosine kinase |
|
- HIV Infection
- Host Interactions of HIV factors
- Cytokine Signaling in Immune system
- The role of Nef in HIV-1 replication and disease pathogenesis
- Nef and signal transduction
- Signaling by Interleukins
- Regulation of signaling by CBL
- Fcgamma receptor (FCGR) dependent phagocytosis
- Interleukin-3, 5 and GM-CSF signaling
- FCGR activation
- Innate Immune System
|
|
- 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- Phosphonotyrosine
- Quercetin
- Bosutinib
|
|
|
ERBB3 and HDAC6 |
erb-b2 receptor tyrosine kinase 3 |
histone deacetylase 6 |
|
- HSF1 activation
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Organelle biogenesis and maintenance
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Assembly of the primary cilium
- Cellular response to heat stress
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
ERBB3 and FLYWCH1 |
erb-b2 receptor tyrosine kinase 3 |
FLYWCH-type zinc finger 1 |
|
|
|
|
|
|
ERBB3 and RASA1 |
erb-b2 receptor tyrosine kinase 3 |
RAS p21 protein activator (GTPase activating protein) 1 |
|
- Signaling by PDGF
- EPHB-mediated forward signaling
- Axon guidance
- VEGFR2 mediated cell proliferation
- Signaling by VEGF
- Downstream signal transduction
- EPH-Ephrin signaling
- VEGFA-VEGFR2 Pathway
|
|
|
|
|
ERBB3 and GRB7 |
erb-b2 receptor tyrosine kinase 3 |
growth factor receptor-bound protein 7 |
|
- Signaling by PDGF
- Signaling by SCF-KIT
- Signaling by ERBB2
- Downstream signal transduction
- GRB7 events in ERBB2 signaling
- Tie2 Signaling
- Cell surface interactions at the vascular wall
|
|
|
|
|
ERBB3 and RPN1 |
erb-b2 receptor tyrosine kinase 3 |
ribophorin I |
|
- Defective ALG2 causes ALG2-CDG (CDG-1i)
- Diseases of glycosylation
- Translation
- Defective ALG3 causes ALG3-CDG (CDG-1d)
- Post-translational protein modification
- SRP-dependent cotranslational protein targeting to membrane
- Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
- Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
- Defective MGAT2 causes MGAT2-CDG (CDG-2a)
- Defective ALG1 causes ALG1-CDG (CDG-1k)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective RFT1 causes RFT1-CDG (CDG-1n)
- Defective ALG6 causes ALG6-CDG (CDG-1c)
- Defective MOGS causes MOGS-CDG (CDG-2b)
- Asparagine N-linked glycosylation
- Defective ALG8 causes ALG8-CDG (CDG-1h)
- Defective ALG9 causes ALG9-CDG (CDG-1l)
- Defective MAN1B1 causes MRT15
- Defective MPDU1 causes MPDU1-CDG (CDG-1f)
- Defective ALG12 causes ALG12-CDG (CDG-1g)
- Diseases associated with N-glycosylation of proteins
- Defective ALG11 causes ALG11-CDG (CDG-1p)
|
|
|
|
|
ERBB3 and PA2G4 |
erb-b2 receptor tyrosine kinase 3 |
proliferation-associated 2G4, 38kDa |
|
|
|
|
|
|
ERBB3 and PIK3R1 |
erb-b2 receptor tyrosine kinase 3 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Metabolism of lipids and lipoproteins
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Interleukin receptor SHC signaling
- PI-3K cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- Signaling by FGFR1 mutants
- Interleukin-7 signaling
- Role of phospholipids in phagocytosis
- Phospholipid metabolism
- Fcgamma receptor (FCGR) dependent phagocytosis
- PI3K Cascade
- Signaling by PDGF
- DAP12 interactions
- GAB1 signalosome
- G-protein beta:gamma signalling
- CD28 co-stimulation
- CD28 dependent PI3K/Akt signaling
- Signaling by ERBB4
- Constitutive PI3K/AKT Signaling in Cancer
- Role of LAT2/NTAL/LAB on calcium mobilization
- PI3K events in ERBB4 signaling
- G alpha (q) signalling events
- Signaling by ERBB2
- Signaling by EGFR
- GPCR downstream signaling
- Signaling by Interleukins
- TCR signaling
- Signaling by VEGF
- GP1b-IX-V activation signalling
- Downstream signal transduction
- Signaling by FGFR mutants
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Nephrin interactions
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- G alpha (q) signalling events
- Downstream TCR signaling
- Costimulation by the CD28 family
- IRS-mediated signalling
- PIP3 activates AKT signaling
- IGF1R signaling cascade
- VEGFA-VEGFR2 Pathway
- Synthesis of PIPs at the plasma membrane
- IRS-related events triggered by IGF1R
- G beta:gamma signalling through PI3Kgamma
- PI3K events in ERBB2 signaling
- Regulation of signaling by CBL
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- PI Metabolism
- Innate Immune System
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- NGF signalling via TRKA from the plasma membrane
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- Signaling by FGFR
- IRS-mediated signalling
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- GPVI-mediated activation cascade
- Interleukin receptor SHC signaling
- Signaling by FGFR1 fusion mutants
- Constitutive Signaling by EGFRvIII
- PI3K Cascade
|
|
- Isoproterenol
- (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
|
|
|
ERBB3 and PIK3R2 |
erb-b2 receptor tyrosine kinase 3 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Metabolism of lipids and lipoproteins
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- Interleukin receptor SHC signaling
- PI-3K cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- Interleukin-7 signaling
- Role of phospholipids in phagocytosis
- Phospholipid metabolism
- Fcgamma receptor (FCGR) dependent phagocytosis
- PI3K Cascade
- Signaling by PDGF
- DAP12 interactions
- GAB1 signalosome
- G-protein beta:gamma signalling
- CD28 co-stimulation
- CD28 dependent PI3K/Akt signaling
- Signaling by ERBB4
- Role of LAT2/NTAL/LAB on calcium mobilization
- Constitutive PI3K/AKT Signaling in Cancer
- PI3K events in ERBB4 signaling
- Signaling by ERBB2
- G alpha (q) signalling events
- Signaling by EGFR
- GPCR downstream signaling
- Signaling by Interleukins
- TCR signaling
- Signaling by VEGF
- Signaling by Rho GTPases
- Downstream signal transduction
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Nephrin interactions
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- G alpha (q) signalling events
- Downstream TCR signaling
- Costimulation by the CD28 family
- IRS-mediated signalling
- PIP3 activates AKT signaling
- IGF1R signaling cascade
- VEGFA-VEGFR2 Pathway
- Rho GTPase cycle
- Synthesis of PIPs at the plasma membrane
- IRS-related events triggered by IGF1R
- G beta:gamma signalling through PI3Kgamma
- PI3K events in ERBB2 signaling
- Regulation of signaling by CBL
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- PI Metabolism
- Innate Immune System
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- IRS-related events
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- NGF signalling via TRKA from the plasma membrane
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- Signaling by FGFR
- IRS-mediated signalling
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- GPVI-mediated activation cascade
- Interleukin receptor SHC signaling
- PI3K Cascade
|
|
|
|
|
ERBB3 and PTK2 |
erb-b2 receptor tyrosine kinase 3 |
protein tyrosine kinase 2 |
|
- Axon guidance
- DCC mediated attractive signaling
- Netrin mediated repulsion signals
- Platelet Aggregation (Plug Formation)
- VEGFA-VEGFR2 Pathway
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- Programmed Cell Death
- EPH-Ephrin signaling
- NCAM signaling for neurite out-growth
- Netrin-1 signaling
- Fcgamma receptor (FCGR) dependent phagocytosis
- Regulation of actin dynamics for phagocytic cup formation
- Innate Immune System
- Apoptotic cleavage of cellular proteins
- Apoptotic execution phase
- p130Cas linkage to MAPK signaling for integrins
- Integrin alphaIIb beta3 signaling
- Signal regulatory protein (SIRP) family interactions
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- Signaling by VEGF
- Platelet activation, signaling and aggregation
|
|
|
|
|
ERBB3 and PIK3R3 |
erb-b2 receptor tyrosine kinase 3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- Metabolism of lipids and lipoproteins
- Signaling by FGFR in disease
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- Interleukin receptor SHC signaling
- PI-3K cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- Interleukin-7 signaling
- Phospholipid metabolism
- Signaling by PDGF
- DAP12 interactions
- GAB1 signalosome
- G-protein beta:gamma signalling
- CD28 co-stimulation
- CD28 dependent PI3K/Akt signaling
- Signaling by ERBB4
- Role of LAT2/NTAL/LAB on calcium mobilization
- Constitutive PI3K/AKT Signaling in Cancer
- PI3K events in ERBB4 signaling
- Signaling by ERBB2
- G alpha (q) signalling events
- Signaling by EGFR
- Signaling by Interleukins
- GPCR downstream signaling
- Downstream signal transduction
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Adaptive Immune System
- G alpha (q) signalling events
- Costimulation by the CD28 family
- PIP3 activates AKT signaling
- Synthesis of PIPs at the plasma membrane
- G beta:gamma signalling through PI3Kgamma
- PI3K events in ERBB2 signaling
- Regulation of signaling by CBL
- Downstream signaling of activated FGFR
- G alpha (12/13) signalling events
- PI Metabolism
- Innate Immune System
- Signalling by NGF
- Cytokine Signaling in Immune system
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- NGF signalling via TRKA from the plasma membrane
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Signaling by FGFR
- GPVI-mediated activation cascade
- Interleukin receptor SHC signaling
|
|
|
|
|
ERBB3 and DAPP1 |
erb-b2 receptor tyrosine kinase 3 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
|
- Signaling by the B Cell Receptor (BCR)
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Adaptive Immune System
|
|
- Inositol 1,3,4,5-Tetrakisphosphate
|
|
|
ERBB3 and SHC1 |
erb-b2 receptor tyrosine kinase 3 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
- Signaling by GPCR
- Signaling by EGFRvIII in Cancer
- Platelet Aggregation (Plug Formation)
- SHC1 events in ERBB2 signaling
- IRE1alpha activates chaperones
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Interleukin receptor SHC signaling
- SHC-mediated signalling
- G-protein beta:gamma signalling
- SHC-related events triggered by IGF1R
- Signaling by ERBB4
- Signaling by ERBB2
- Signaling by EGFR
- Signaling by Interleukins
- GPCR downstream signaling
- SHC1 events in ERBB4 signaling
- Signalling to RAS
- Signaling by EGFR in Cancer
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
- Signalling to ERKs
- IGF1R signaling cascade
- XBP1(S) activates chaperone genes
- G beta:gamma signalling through PI3Kgamma
- Unfolded Protein Response (UPR)
- Signaling by Insulin receptor
- Signalling by NGF
- Insulin receptor signalling cascade
- SHC-mediated signalling
- Integrin alphaIIb beta3 signaling
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- Cytokine Signaling in Immune system
- NGF signalling via TRKA from the plasma membrane
- SHC-related events
- Tie2 Signaling
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Cell surface interactions at the vascular wall
- SHC1 events in EGFR signaling
- Signal attenuation
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Constitutive Signaling by EGFRvIII
- SHC activation
|
|
|
|
|
ERBB3 and FER |
erb-b2 receptor tyrosine kinase 3 |
fer (fps/fes related) tyrosine kinase |
|
|
|
|
|
|
ERBB3 and GRB2 |
erb-b2 receptor tyrosine kinase 3 |
growth factor receptor-bound protein 2 |
|
|
|
- Pegademase bovine
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
ERBB3 and NRG2 |
erb-b2 receptor tyrosine kinase 3 |
neuregulin 2 |
|
- Signaling by the B Cell Receptor (BCR)
- Signaling by FGFR in disease
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Signaling by EGFRvIII in Cancer
- Signaling by SCF-KIT
- SHC1 events in ERBB2 signaling
- Downstream signaling events of B Cell Receptor (BCR)
- DAP12 signaling
- PI3K/AKT activation
- PI-3K cascade
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Downstream signaling of activated FGFR
- Innate Immune System
- Signaling by PDGF
- Downregulation of ERBB2:ERBB3 signaling
- Signalling by NGF
- DAP12 interactions
- GAB1 signalosome
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- NGF signalling via TRKA from the plasma membrane
- Signaling by ERBB4
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- Role of LAT2/NTAL/LAB on calcium mobilization
- Constitutive PI3K/AKT Signaling in Cancer
- PI3K events in ERBB4 signaling
- Signaling by FGFR
- Signaling by ERBB2
- Signaling by EGFR
- Nuclear signaling by ERBB4
- SHC1 events in ERBB4 signaling
- Downstream signal transduction
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- PI3K/AKT Signaling in Cancer
- Adaptive Immune System
|
|
|
|
|